Blog

Knowledge & Insights

Everything about compounding pharmacy, personalised weight management and pharmacies in the Netherlands.

Money & Access 6 min2026-04-11

Generic Semaglutide vs Ozempic: Is It the Same Medicine?

Generic semaglutide is now launching in India, Canada, and Brazil. Is it the same as Ozempic? Here's what equivalence actually means — and what to look for.

Read more
Money & Access 7 min2026-04-11

Why Ozempic Costs So Much: The Patent Story Every Patient Should Know

Ozempic costs €300+ per month in some countries and €14 in others. Here's the patent economics behind the price — and why 2026 is changing everything.

Read more
Practical Journey 10 min2026-04-11

Starting a GLP-1 Weight Management Programme: A Practical Patient Guide

Considering semaglutide for weight management? Here's what to expect in week 1, month 1, and beyond — from dose titration to side effects to lifestyle pairings.

Read more
Science & Safety 6 min2026-04-11

Authentic vs Grey Market Semaglutide: How to Protect Yourself

Counterfeit and grey market semaglutide is a growing problem. Here's how to tell if what you're buying is the real thing — and what to do if you're not sure.

Read more
Money & Access 8 min2026-04-11

Semaglutide in India 2026: What Patent Expiry Means for Price and Access

India's semaglutide patent expired March 20, 2026. Within 48 hours, 15 generic versions launched at ₹1,290/month — a 90% drop from Ozempic. Here's what it means for Indian patients.

Read more
Science & Safety 7 min2026-04-11

How Semaglutide Works in Your Body (Without the Hype)

A clear, non-hype explanation of what semaglutide actually does inside your body — the gut, the brain, the pancreas — and why that matters for how you take it.

Read more
Science & Safety 8 min2026-04-11

Ozempic vs Wegovy vs Mounjaro: Which GLP-1 Is Right for You?

Three brand names, two molecules, very different labels. Here's an honest comparison of Ozempic, Wegovy, and Mounjaro — what the differences actually mean for patients.

Read more
Practical Journey 8 min2026-04-11

The Nausea Playbook: Managing the First Month on Semaglutide

Nausea is the most common reason people stop semaglutide in the first month. Here's a practical, evidence-based playbook for getting through the first four weeks.

Read more
Science & Safety 7 min2026-04-11

Who Should NOT Take GLP-1 Weight Loss Medication

GLP-1 drugs like semaglutide and tirzepatide are not for everyone. Here's an honest list of who should not take them, and why — from contraindications to caution cases.

Read more
Practical Journey 8 min2026-04-11

Diet Pairings That Maximise GLP-1 Weight Loss

GLP-1 drugs do a lot, but diet still matters — maybe more than you think. Here's what to eat to protect muscle, avoid nausea, and get the most out of semaglutide.

Read more
Science 5 min2026-04-07

New weight loss drug linked to emotional side effects: what we know

Retatrutide, an experimental triple-agonist weight loss drug, has been linked to emotional blunting and reduced romantic feelings. What does the science say?

Read more
Science 7 min2026-04-06

How do weight management molecules work? The chemistry explained simply

From GLP-1 to dual and triple agonists: how do these molecules work in your body? The chemistry behind weight management, explained without jargon.

Read more
Safety 6 min2026-04-06

Risks and side effects of weight management medication: what you need to know

An honest overview of the side effects, risks and safety data of weight management medication. What does the science say? And how do you minimise risks?

Read more
Weight Management 4 min2026-04-06

Dietitian not enough? When medical support makes sense

You visit your dietitian but the weight won't budge. When is it time for medical support alongside nutritional advice? And what does it cost in 2026?

Read more
Weight Management 5 min2026-04-05

Diet programme didn't work? Here are your options in 2026

Tried Weight Watchers, Noom or another diet programme without results? Discover why dieting alone often isn't enough and what medical alternatives are available.

Read more
Costs 5 min2026-04-05

Weight loss medication not covered by insurance? Your options in 2026

Branded medications for weight loss cost €250-500/month and are not reimbursed in 2026. Discover the affordable alternative via compounding: from €155/month.

Read more
Costs 4 min2026-04-05

Affordable weight loss with medical support in the Netherlands

Medical weight loss doesn't have to be expensive. Compare the costs of every option in the Netherlands: from dietitians to compounding pharmacies. Discover the affordable alternative.

Read more
Education 5 min2026-04-04

What is compounding? Everything you need to know

Compounding is the custom preparation of medication by a pharmacist. Discover how it works, why it's legal, and what the advantages are compared to standard branded products.

Read more
Weight Management 4 min2026-04-04

Personalised weight loss in the Netherlands: the new approach

Discover why more and more Dutch people are choosing personalised weight management programmes via compounding pharmacies. Affordable, effective and under medical supervision.

Read more
Comparison 4 min2026-04-04

Compounding pharmacy vs. branded products: what's the difference?

Compare compounded preparations with standard branded products. Costs, quality, dosage and safety — everything laid out for Dutch consumers.

Read more
Practical 3 min2026-04-04

How does personalised weight management work via Magistra?

Step-by-step explanation of the Magistra platform: from questionnaire to home delivery. How to start a personalised weight management programme in 4 steps.

Read more
Safety 5 min2026-04-04

Is compounding safe? Quality and regulation in the Netherlands

How safe are compounded preparations? An overview of Dutch and European regulation, quality controls and registration requirements for compounding pharmacies.

Read more
Costs 4 min2026-04-05

Weight management costs in the Netherlands 2026: what do you really pay?

An honest comparison of the costs of weight management programmes in the Netherlands. From dietitians to branded products to compounding — what does it really cost?

Read more
Practical 3 min2026-04-05

Compounding pharmacy near me: how do you find one?

How do you find a licensed compounding pharmacy in the Netherlands? What should you look for? And how does Magistra simplify the search?

Read more
Health 4 min2026-04-05

Calculate your BMI: when is it time to take action?

Calculate your BMI and discover when a personalised weight management programme makes sense. With an explanation of BMI categories and your options in the Netherlands.

Read more
Privacy 4 min2026-04-05

Privacy: is it safe to share health data online?

How does Magistra protect your health data? An overview of GDPR compliance, EU hosting and the security measures that safeguard your privacy.

Read more
Education 4 min2026-04-05

The difference between diet pills and compounding

Diet pills vs. compounding: what's the difference? Why personalised programmes via a doctor and pharmacy are safer and more effective.

Read more
Money & Access 12 min2026-04-26

Chinese Gray-Market GLP-1 Peptides in 2026: What the Lab Tests Actually Show

An evidence-grounded look at the Chinese semaglutide and tirzepatide peptide trade — what's really in the vial, what independent third-party testing reveals, the legal reality, and what patients should know before relying on this supply chain.

Read more
Money & Access 16 min2026-04-26

GLP-1 Supply-Demand Forecast 2026-2030: When Does Supply Catch Up With Demand?

An evidence-grounded forecast of GLP-1 medication supply and demand through 2030. Manufacturing capacity, generic ramp, demand drivers (cardiovascular, kidney, sleep apnea, oral formulations), the role of insurance unlock, and what the 2031 OECD generic wave actually means for affordability.

Read more
Money & Access 18 min2026-04-26

GLP-1 Global Trading 2026-2031: Patent Arbitrage, Medical Tourism, Customs Reality

What happens when one country has $40/month generic semaglutide and another has $1,349/month branded — until 2031? An evidence-grounded look at the legal arbitrage now opening up: who travels to India, what gets through customs, the difference between the Indian-generic gray market and the Chinese-peptide gray market, and how the trade likely evolves.

Read more
Money & Access 8 min2026-04-26

The New UK GPhC Rules on Weight-Loss Jabs: What Patients and Doctors Need to Know (April 2026)

In January 2026 the GPhC tightened the rules on how UK pharmacies can supply Wegovy, Mounjaro and other weight-loss jabs. Online questionnaire-only prescribing is no longer permitted; pharmacies must conduct a two-way consultation and independently verify BMI. Here's what changed, why, and what it means for patients seeking treatment and doctors providing it.

Read more
Safety & Quality 10 min2026-04-29

The UK GLP-1 Grey Market: 135 Companies, 1 Death, and Why the Safe Path Matters

We audited every UK company with 'peptide' in its name on Companies House. 98 are brand new with no track record, none of the credible ones supply GLP-1, and one woman has already died. Here's what patients need to know — and the safe alternative.

Read more

Personalised weight management, doctor-guided

Free Questionnaire